Report ID: SQMIG35C2014
Report ID:
SQMIG35C2014 |
Region:
Global |
Published Date: February, 2024
Pages:
255
|
Tables:
60 |
Figures:
75
North America's market was the most profitable and held the largest share in 2021, accounting for more than 42.0% of total revenue generated worldwide. This is primarily due to the region's dominance in the biologics and pharmaceutical medication markets, as well as an increase in the number of biopharmaceuticals shipped out of and brought into the region. Furthermore, due to the high cost of medical treatment, the region has a relatively high rate of adoption of various cutting-edge technologies.
The Asia-Pacific region's fastest growth is due to a few factors, including an increasing need for pharmaceuticals among an ageing population, the adoption of technologically enhanced services, and the developing economic conditions in emerging countries such as China and India. Furthermore, the fact that an increasing number of patents will expire in the coming years indicates that there will be a significant shift in the market share of medicine sales away from the original brand manufacturer and toward generic ones. This aspect is expected to increase pharmaceutical sales, as well as import and export. The prevalence of a growing number of diseases is driving up demand for pharmaceuticals and biologics. Because of the high prevalence of type 2 diabetes patients in Asia-Pacific, for example, there is a greater need for insulin in those regions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35C2014